Literature DB >> 34053008

Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience.

D Cattaneo1,2, L Pasina3, F Conti4, A Giacomelli4, L Oreni4, L Pezzati4, C Bonazzetti4, M Piscaglia4, G Carrozzo4, S Antinori4, C Gervasoni5,6.   

Abstract

Entities:  

Year:  2021        PMID： 34053008     DOI： 10.1007/s40618-021-01604-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  1 in total

Review 1.  Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.

Authors:  Charles Awortwe; Ingolf Cascorbi
Journal:  Pharmacol Res       Date:  2020-10-13       Impact factor: 7.658
  1 in total
  1 in total

1.  Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.

Authors:  Levin Thomas; Sumit Raosaheb Birangal; Rajdeep Ray; Sonal Sekhar Miraj; Murali Munisamy; Muralidhar Varma; Chidananda Sanju S V; Mithu Banerjee; Gautham G Shenoy; Mahadev Rao
Journal:  Ther Adv Drug Saf       Date:  2021-08-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.